Direct the FDA and HHS to ensure drugs in the U.S. supply chain are not made by companies affiliated with the Chinese Communist Party.

The Securing America’s Drug Supply from Communist China Act directs the Food and Drug Administration (FDA) and the Department of Health and Human Services (HHS) to ensure that drugs in the U.S. supply chain are not made by companies affiliated with the CCP.

Cotton introduced legislation to bar CCP-affiliated companies from making drugs in the U.S. supply chain.

Cotton Introduces Bill to Eliminate National Security Risk Posed by CCP-Affiliated Drugs
primary · press_release · model gpt-5.4-mini

Sen. Tom Cotton said he introduced the Securing America’s Drug Supply from Communist China Act. The release says the bill would direct FDA, working with HHS, to make sure drugs in the U.S. supply chain are not made by companies affiliated with the CCP, and it would review Chinese-entity drug products and related applications.

Concrete legislative action inside the lookback window, but only at introduction; it does not show enactment or agency implementation.

unresolved same_term A for effort

Cotton Introduces Bill to Eliminate National Security Risk Posed by CCP-Affiliated Drugs
primary · model gpt-5.4-mini · confidence 98%

GovInfo records that Cotton introduced S. 4327, which was read twice and referred to the Senate Committee on Health, Education, Labor, and Pensions. The bill title and summary match the claim’s directive to have FDA and HHS ensure drugs are not made by CCP-affiliated companies.

Official bill record confirms introduction and committee referral, but no later passage or executive action is shown in the lookback window.

unresolved same_term A for effort

S. 4327 (IS) - Securing America’s Drug Supply from Communist China Act - GovInfo
secondary · model gpt-5.4-mini · confidence 97%